Sun Pharma Aciclovir 400 mg Tablets

Sun Pharma Aciclovir 400 mg Tablets are a prescription-only antiviral medication primarily used to treat infections caused by the herpes simplex virus, such as cold sores and genital herpes, as well as varicella-zoster virus (chickenpox and shingles). The brand is part of the extensive portfolio of Sun Pharmaceutical Industries Ltd., which was founded in 1983 by Dilip Shanghvi in Mumbai, India. Initially starting with just five psychiatric products, Sun Pharma has grown into the fourth-largest specialty generic pharmaceutical company in the world.

While the marketing authorization for the UK is held by Sun Pharma UK Limited, based in Uxbridge, the actual manufacturing of these tablets occurs at multiple global sites. These include facilities such as Terapia S.A. in Cluj-Napoca, Romania, and Sun Pharmaceutical Industries Europe BV in the Netherlands. This global supply chain is characteristic of the company's vertically integrated business model, which leverages over 40 manufacturing sites across several continents to ensure product availability.

Ownership of the brand remains firmly under Sun Pharmaceutical Industries Ltd., an Indian multinational company. The founding family, led by Dilip Shanghvi, continues to hold a majority stake in the business, which is publicly traded on the Bombay Stock Exchange and the National Stock Exchange of India. The company's expansion into the UK market was significantly bolstered by its acquisition of Ranbaxy Laboratories in 2014, a move that integrated various local operations and strengthened its presence within the National Health Service (NHS) supply chain.